Factors to consider before using Flibanserin drug; There are several factors that women with Hypoactive Sexual Desires Disorder need to consider before deciding to use Flibanserin drug. One of the factors is allergic reactions to
the medicine. Women are encouraged to tell their doctors any type of allergies. Secondly,
Flibanserin should not be used by children. Third, the safety and efficacy of the medicine
have not been established among the elderly. This means that the drug is not recommended
for use among the elderly. Fourth, Flibanserin should not be used together with other drugs.
Flibanserin is only prescribed to women above the age of 18 years who meet the Stage of
Reproductive Aging Workshop (STRAW) criteria (Sang, Kim, & Kim, 2016). The STRAW
criteria require that women requesting for Flibanserin prescription have a regular menstrual
cycle of between 21 and 35 days in the previous twelve months (Sang, Kim, & Kim, 2016). Order
It also requires the woman to have a normal level of follicle-stimulating hormone (FSH). Most
importantly, the prescription should only be done if the woman requesting it has been
diagnosed with HSDD according to the DSM-IV-TR criteria (Sang, Kim, & Kim, 2016).
Hypoactive sexual desire disorder (HSDD) also known as an inhibited sexual disorder
(ISD) or hyposexuality is sexual dysfunction characterized by a lack of sexual activity desires
or sexual fantasies (Joffe et al., 2016). For it to be called a disorder, the condition must cause
distress and not be as a result of another mental disorder, a medical condition, or a drug. Factors to consider before using Flibanserin drug
Women with HSDD do not respond to their partners’ desire for sexual activity. Clayton et al.
(2020) posits that approximately 10 percent of premenopausall women in the United States
are affected by HSDD. Although there is no specific cause of HSDD, it is often associated
with medical problems, fewer levels of testosterone, psychiatric problems, or high prolactin
levels (Clayton et al., 2020). Other scholars argue that HSDD is associated with an imbalance
between neurotransmitters with excitatory activity and neurotransmitters with inhibitory
activities. Apart from Flibanserin, the other medication for the treatment of HSDD is
bremelanotide and was approved in the year 2019. Factors to consider before using Flibanserin drug;
